EF MEDISPA launch FemiLift - a new, non-surgical, quick and safe solution for stress incontinence. Thursday 23 February 2017 PDF Print Seeking a female health journalist as a case study to trial recently launched laser treatment for stress incontinence. Must be willing to write a personal testimony to be featured in the press. Names can be changed for privacy. Please see more information on the treatment below. EF MEDISPA launch the FemiLift - a new, non-surgical, quick and safe solution for various common feminine issues. FemiLift is a minimally invasive laser treatment addressing a wide range of feminine health concerns such as stress urinary incontinence (bladder weakness) and vaginal dryness, caused by child birth, menopause and hormonal changes. Offering long-lasting results that constantly improve over a full course of treatments, FemiLift is a state-of-the-art, safe and FDA approved treatment. One of the most significant advantages of this treatment is that it is quick and painless. It takes less than 30 minutes and doesn’t involve surgery or extensive downtime. Like skin, vaginal tissue is made up of collagen fibres which give it strength and flexibility. FemiLift uses breakthrough CO2 laser technology to gently heat vaginal tissue, contracting existing fibres and stimulating the formation of new collagen. This improves the functionality of the entire vaginal area, normalizing blood flow, increasing lubrication, boosting immune resistance and restoring the strength and elasticity of the vaginal walls. Performed by a trained gynaecologist, FemiLift, involves using a uniquely-designed laser probe enclosed within a single-use tube to protect both the probe and the skin. The pixel laser then emits light energy to the surrounding vaginal tissue triggering collagen production that leads to the tightening of the vaginal cavity. Esther Fieldgrass, EF MEDISPA founder says, ‘As a medispa owner I’m always looking at the future of integrated medicine and how I can enhance not only womens beauty but also their health. Femilift is a breakthrough laser treatment for those who suffer from stress urinary incontinence and want to avoid surgery. This treatment is already huge in the States and we are proud to be one of the first medispas to offer this to our UK clients.” Clinical trials: According to the manufactured supported, retrospective study, which was published in 2016 by Dr Alcalay Menachem and Dr Bader Alexander, 133 patients participated in a study, of which 80% had stress incontinence symptoms and 20% had mixed incontinence symptoms. After having CO2 laser treatment it was reported that a significant decline in number of incontinence pads used per day, with 80% of patients requiring no pads. Significant reduction in urinary urgency and frequency were reported, with more than 97% of patients reporting none or mild urgency and frequency following treatment. In additional 91.4% of the patients reported no pain during sexual intercourse. • Course of three treatments recommended • Duration of Results: up to 2 years Please contact: PR Manager Zoe Stebbing for more information: Tel: 020 7122 4917 firstname.lastname@example.org This press release was distributed by ResponseSource Press Release Wire on behalf of EF Medispa in the following categories: Health, Women's Interest & Beauty, Medical & Pharmaceutical, for more information visit http://pressreleasewire.responsesource.com/about.